Surgical Implant Or Material Patents (Class 424/423)
-
Patent number: 11173233Abstract: A malleable bone graft composition is described. The composition comprises: (a) keratose; (b) particulate filler; (c) antibiotic; and (d) water. The invention may be provided in sterile form in an container, and optionally lyophilized. Methods of treating a fracture with such compositions are also described.Type: GrantFiled: November 19, 2014Date of Patent: November 16, 2021Assignee: Wake Forest University Health SciencesInventor: Mark E. Van Dyke
-
Patent number: 11173234Abstract: A three-dimensional electrospun nanofiber scaffold for use in repairing a defect in a tissue substrate is provided. The three-dimensional electrospun nanofiber scaffold includes a first layer formed by a first plurality of electrospun polymeric fibers and a second layer formed by a second plurality of electrospun polymeric fibers. The second layer is coupled to the first layer using a coupling process and includes a plurality of varying densities formed by the second plurality of electrospun polymeric fibers. The first and second layers are configured to degrade via hydrolysis after at least one of a predetermined time or an environmental condition. The three-dimensional electrospun nanofiber scaffold is configured to be applied to the tissue substrate containing the defect.Type: GrantFiled: April 13, 2021Date of Patent: November 16, 2021Assignee: Washington UniversityInventor: Matthew R. MacEwan
-
Patent number: 11168305Abstract: This invention provides an isolated disc stem cell population, compositions, and methods of obtaining and growing the same. Moreover, this invention provides an isolated discosphere, compositions, and methods of obtaining and growing the same. An artificial disc containing the cells of the present invention is provided together with methods of making the same. This invention also provides a method of treating a subject having a herniated disc utilizing the cells and methods of the invention.Type: GrantFiled: November 8, 2016Date of Patent: November 9, 2021Assignee: DiscGenics, Inc.Inventors: Valery Kukekov, Christopher Duntsch, Tatyana Ignatova
-
Patent number: 11167013Abstract: The present disclosure relates to a composition for the release of the bioactive substance comprising: sucrose acetate isobutyrate dissolved in an ionic liquid and an additive selected from the list consisting of: chitin, silk fibroin, cellulose, alginate, chitosan, gellan gum, dextrin, collagen, guar gum, carregeenan, heparin, kefiran, or mixtures thereof. By taking advantage of the properties of an ionic liquid (IL), in particular 1-butyl-imidazolium acetate (BMIMAc), it was possible to achieve a good dissolution of SAIB, which combined with chitin and/or silk, natural polymers, allows the development of the structures with different shape and sizes.Type: GrantFiled: June 11, 2018Date of Patent: November 9, 2021Assignee: ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING CELL BASED TECHNOLOGIES & THERAPIES (A4TEC)—ASSOCIAÂOInventors: Cristiana Da Mota Martins Gonçalves, Simone Dos Santos Silva, Fátima Raquel Azevedo Maia, Hajer Radhouani, Joaquim Miguel Antunes Correia De Oliveira, Rui Luís Gonçalves Dos Reis
-
Patent number: 11154354Abstract: Apparatuses and methods for treating a heart failure patient by ablating a nerve of the thoracic splanchnic sympathetic nervous system to increase venous capacitance and reduce pulmonary blood pressure. A method comprising: inserting a catheter into a vein adjacent the nerve, applying stimulation energy and observing hemodynamic effects, applying ablation energy and observing hemodynamic effects, applying stimulation energy after the ablation and observing hemodynamic effects and monitoring for presence of the lung in the ablation zone. An alternative method comprising: inserting a catheter into a vein adjacent the nerve, detecting that lung tissue is a safe distance from an ablation zone, and delivering ablation energy to the target nerve when lung tissue is a safe distance from the ablation zone.Type: GrantFiled: July 31, 2017Date of Patent: October 26, 2021Assignee: Axon Therapies, Inc.Inventors: Howard Levin, Mark Gelfand, Zoar Jacob Engelman, Dorin Panescu, Mark S. Leung
-
Patent number: 11141277Abstract: One embodiment of the present invention is directed to compositions and methods for enhancing attachment of soft tissues to a metal prosthetic device. In one embodiment a construct is provided comprising a metal implant having a porous metal region, wherein said porous region exhibits a nano-textured surface.Type: GrantFiled: March 11, 2020Date of Patent: October 12, 2021Assignee: PURDUE RESEARCH FOUNDATIONInventors: Thomas J. Webster, Venu Perla
-
Patent number: 11135155Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.Type: GrantFiled: October 31, 2018Date of Patent: October 5, 2021Assignee: Hikma Pharmaceuticals USA Inc.Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
-
Patent number: 11136470Abstract: The present invention relates to a polyvinyl-based compound, which maximizes self-healing ability by introducing various functional molecules into a brush of a polyvinyl-based resin, a preparation method thereof, and a polymer coating film produced therefrom.Type: GrantFiled: April 12, 2018Date of Patent: October 5, 2021Assignees: CEKO CO., LTD., DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC, POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Moon Hor Ree, Kyung Ho Kwon, Won Yeong Ryu, Kwan Young Han, Sung Kyoo Lim, Byung Min Park, Dong Hoon Jang, Hyun Joong Kim, Hong Chul Kim, Jeong Rae Kim
-
Patent number: 11129706Abstract: The present invention relates to a coating composition for an in-vivo implantable prosthesis including a photoinitiator, a crosslinking agent, and a phosphorylcholine (PC) monomer having an acrylate group, a method of coating an in-vivo implantable prosthesis using the coating composition, and a cosmetic prosthesis coated with the crosslinked polyphosphorylcholine. An in-vivo implantable prosthesis coated with crosslinked polyphosphoryicholine may be manufactured by a simple method of applying a coating composition including a photoinitiator, a crosslinking agent, and a phosphorylcholine (PC) monomer having an acrylate group according to the present invention, and then irradiating UV rays. The crosslinked polyphosphorylcholine coating may provide hydrophilicity for the surface and may also remarkably reduce adsorption of proteins and fibroblasts, which may cause side effects such as capsular contracture.Type: GrantFiled: April 17, 2015Date of Patent: September 28, 2021Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, BS RESEARCH CO. LTD.Inventors: Tae Hyun Choi, Yan Lee, Ji Ung Park, Ji Yeon Ham, Hee Jin Kim, Suk Wha Kim, Hye Jeong Min
-
Patent number: 11123397Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.Type: GrantFiled: September 11, 2017Date of Patent: September 21, 2021Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.Inventors: Tamar Auerbach-Nevo, Ashley Deanglis, Israel Nur
-
Patent number: 11124897Abstract: Coaxial electrospinning is used to encapsulate a chitin-lignin based hybrid gel with polycaprolactone (PCL). Antibiotics and/or other bioactive agents loaded into the core and/or shell layer of the fibrous platform are released in a controlled and sustained manner that effectively inhibits both Gram-positive and Gram-negative bacteria without cytotoxicity to mammalian cells. The PCL shell layer provides longer life for the CL gels in a wet environment and allows sustainable drug release. The PCL-coated CL nanofiber scaffolds can be loaded with antimicrobial nanoparticles, antibiotics, oxygen-releasing agents, antioxidants and/or growth factors that promote healing when used as a controlled drug release dressing for chronic wounds, such as diabetic ulcers.Type: GrantFiled: September 17, 2020Date of Patent: September 21, 2021Assignee: King Abdulaziz UniversityInventors: Tuerdimaimaiti Abudula, Kalamegam Gauthaman, Ahmed Alshahrie, Numan Salah, Adnan Memic
-
Patent number: 11118025Abstract: Novel absorbable foams, lyophilizing solutions, and lyophilizing and annealing processes are disclosed. The foams are made from copolymers of glycolide and epsilon-caprolactone. The foams are useful in or as implantable medical devices.Type: GrantFiled: January 8, 2018Date of Patent: September 14, 2021Assignee: Ethicon, Inc.Inventors: Jackie Donners, Marc Wisnudel, Mark Timmer
-
Patent number: 11111362Abstract: Films for medical devices and/or packaging include polyethylene-poly(ethylene oxide) amphiphilic graft copolymers (PE-g-PEO) in their base polymer formulations of polyethylene and poly(ethylene oxide). The films may be treated to include a nitric-oxide releasing agent incorporated into the PE-g-PEO. Also, microbial agents for inclusion in medical devices are provided, which comprise: an olefin-poly(ethylene oxide) amphiphilic graft copolymer, wherein a portion of the poly(ethylene oxide) comprises end groups converted to a nitric oxide-releasing agent. The amphiphilic graft copolymer of the microbial agents may comprise a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO), a polypropylene-poly(ethylene oxide) amphiphilic graft copolymer (PP-g-PEO), or mixtures thereof.Type: GrantFiled: September 21, 2017Date of Patent: September 7, 2021Assignee: Becton, Dickinson and CompanyInventors: Jianbin Zhang, Theresa Hermel-Davidock, Edward Bryan Coughlin
-
Patent number: 11103460Abstract: Embodiments of the present disclosure include devices, and methods of making such devices, for delivery of one or more active agents with short or long zero-order release kinetics. Embodiments also include implantable or injectable drug delivery systems capable of controlled release over long periods of time for therapeutic agents.Type: GrantFiled: August 6, 2018Date of Patent: August 31, 2021Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Paul S. Ho, Junjun Liu, Tengfei Jiang, Salomon A. Stavchansky
-
Patent number: 11090337Abstract: A method of generating photoreceptors is disclosed. Cell populations comprising photoreceptors and uses thereof are also disclosed.Type: GrantFiled: August 4, 2016Date of Patent: August 17, 2021Assignee: CELL CURE NEUROSCIENCES LTDInventor: Osnat Bohana-Kashtan
-
Patent number: 11083719Abstract: The invention relates to a gel composition containing pirfenidone, which is advantageous over other cutaneously administered pharmaceutical forms known in the prior art and which can be used in treatment for the restoration of tissues with fibrotic lesions and for the prevention of fibrotic lesions.Type: GrantFiled: June 24, 2019Date of Patent: August 10, 2021Assignee: Excalibur Pharmaceuticals, Inc.Inventors: José Agustín Rogelio Magaña Castro, Laura Vázquez Cervantes, Juan Socorro Armendáriz Borunda
-
Patent number: 11077229Abstract: Methods of reducing or preventing an adverse response to an implanted or inserted material in a patient are provided. The methods include the step of treating at least a portion of an external surface of the implanted or inserted material with an effective amount of a birth tissue material coating corn position.Type: GrantFiled: March 10, 2014Date of Patent: August 3, 2021Assignee: BioDLogics, LLCInventor: Timothy R. Brahm
-
Patent number: 11065201Abstract: The present invention relates to a composition comprising non-water soluble carbohydrates, wherein at least 50% of the non-water soluble carbohydrates are carbohydrates selected from derivatives of lactose, maltose, trehalose, raffinose, glucosamine, galactosamine, lactosamine, or derivatives of disaccharides with at least two pyranose saccharide units, trisaccharides, tetrasaccharides, or mixtures thereof, and wherein the composition is a liquid before administration into the human or animal body and increases in viscosity by more than 1,000 centipoise (cP) after administration, for use as a medicament.Type: GrantFiled: November 20, 2015Date of Patent: July 20, 2021Assignee: TECHNICAL UNIVERSITY OF DENMARKInventors: Thomas Lars Andresen, Linda Maria Bruun, Trine Bjørnbo Larsen, Rasmus Irming Jølck, Anders Elias Hansen
-
Patent number: 11058534Abstract: Tubular prostheses are provided for use in airways, upper digestive, and urinary tracts. Each of these uses has its own specific sets of biological specifications, based on what it must contain and exclude and the physical and chemical pressures and stresses to which it is subjected. The prostheses may be made from allogeneic cells. Thus they can be manufactured and stored prior to an individual's personal need arising.Type: GrantFiled: November 7, 2018Date of Patent: July 13, 2021Assignees: Humacyte, Inc, Yale UniversityInventors: Laura Niklason, Angela Huang, Liping Zhao, Shannon Dahl
-
Patent number: 11058740Abstract: The present disclosure relates to a composition for preventing, alleviating or treating stress diseases, containing a Platycodon grandiflorum extract as an active ingredient, and, more specifically, to a food composition for preventing or alleviating stress diseases or a pharmaceutical composition for preventing and treating stress diseases, both of which contain a Platycodon grandiflorum extract and a Citrus aurantium extract as active ingredients. A method of the present disclosure can be used for the preparation of an agent for treating depression and anxiety, which are stress diseases, with few side effects because of the use of a natural material, and a health functional food having effects of alleviating depression, anxiety and fatigue, which are stress diseases.Type: GrantFiled: April 18, 2018Date of Patent: July 13, 2021Assignee: SUNG KYUN BIOTECH CO., LTD.Inventors: Mi Rim Jin, Do Heon Lee, Sun Yeou Kim
-
Patent number: 11058780Abstract: The present invention relates to a palpable marker composition comprising non-water soluble carbohydrates, wherein at least 50% of the non-water soluble carbohydrates are carbohydrates selected from derivatives of lactose, maltose, trehalose, raffinose, glucosamine, galactosamine, lactosamine, or derivatives of disaccharides with at least two pyranose saccharide units, trisaccharides, tetrasaccharides, or mixtures thereof, and wherein the composition is a liquid before administration into the human or animal body and increases in viscosity by more than 50,000 centipoise (cP) after administration, for use for identifying and/or locating a non palpable tumor. In one embodiment the composition the composition is a liquid before administration into the human or animal body that increases in viscosity by more than 500,000 centipoise (cP) after administration into the human or animal body.Type: GrantFiled: May 19, 2017Date of Patent: July 13, 2021Assignees: TECHNICAL UNIVERSITY OF DENMARK, NANOVI RADIOTHERAPY APSInventors: Thomas Lars Andresen, Rasmus Irming Jølck, Linda Maria Bruun
-
Patent number: 11060074Abstract: The present invention provides polymer brush constructs, for example, surfaces decorated with hyaluronan polymers, and methods of making the same. The constructs are useful as functional materials for numerous applications, e.g., as lubricants, implant coatings, bandages and other uses.Type: GrantFiled: March 11, 2019Date of Patent: July 13, 2021Assignee: Georgia Tech Research CorporationInventors: Jennifer E. Curtis, M. G. Finn, Wenbin Wei, Jessica Faubel
-
Patent number: 11052050Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Farther, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging.Type: GrantFiled: November 15, 2016Date of Patent: July 6, 2021Assignee: Varian Medical Systems, Inc.Inventors: Philipp Harder, Olaf Fritz, Ulf Fritz
-
Patent number: 11045426Abstract: The present disclosure utilises 3D printing technology, particularly fused filament fabrication, FFF, 3D printing, in conjunction with solid and/or liquid dispensers to produce solid dosage forms, such as pharmaceutical capsules. Such solid dosage forms have a shell, which is 3D printed, and a core, which is dispensed.Type: GrantFiled: July 25, 2017Date of Patent: June 29, 2021Assignee: UNIVERSITY OF CENTRAL LANCASHIREInventors: Mohamed Albed Alhnan, Tochukwu Chijioke Okwuosa
-
Patent number: 11045580Abstract: An implantable medical product and method of use for substantially reducing or eliminating harsh biological responses associated with conventionally implanted medical devices, including inflammation, infection and thrombogenesis, when implanted in in a body of a warm blooded mammal. The bioremodelable pouch structure is configured and sized to receive, encase and retain an electrical medical device therein and to allow such device to be inserted into the internal region or cavity of the pouch structure; with the pouch structure formed from either: (a) first and second sheets, or (b) a single sheet having first and second sheet portions. After receiving the electrical device, the edges around the opening are closed by suturing or stapling. The medical device encased by the bioremodelable pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in the body of the mammal.Type: GrantFiled: December 19, 2018Date of Patent: June 29, 2021Assignee: AZIYO MED, LLCInventor: Robert G. Matheny
-
Patent number: 11040006Abstract: The present invention relates generally to topical antiviral compositions, delivery systems, and methods of using the same.Type: GrantFiled: April 6, 2020Date of Patent: June 22, 2021Assignee: Novan, Inc.Inventors: Kimberly McHale, Ryan Doxey, Nathan Stasko
-
Patent number: 11043286Abstract: A system and method for design of polymeric carrier for controlled release of molecules is provided. The method includes receiving a plurality of input parameters of a polymeric carrier, a solvent, and molecules to be released from the polymeric carrier from a database and performing Molecular Dynamics (MD) simulations to estimate thermodynamic and transport properties of the polymeric carrier, the solvent and the molecules to be released using on one or more input parameters from the plurality of input parameters. Based on the estimated thermodynamic and transport properties, swelling and degradation kinetics of the polymeric carrier and release kinetics of the molecules to be released from the polymeric carrier is estimated and generating a proposed formulation based on difference between estimated released kinetics and the targeted release kinetics of the molecules.Type: GrantFiled: February 6, 2018Date of Patent: June 22, 2021Assignee: TATA CONSULTANCY SERVICES LIMITEDInventors: Venkataramana Runkana, Beena Rai, Aditya Pareek, Balarama Sridhar Dwadasi, Rakesh Gupta
-
Patent number: 11040020Abstract: A sulfonamide pharmaceutical composition. The present invention relates to a sulfonamide compound injectable preparation comprising a sulfonamide compound or a derivative thereof. The injectable preparation is prepared from the sulfonamide compound and a pharmaceutically acceptable carrier through certain preparation technologies. The sulfonamide compound injectable preparation involved in the present invention is stable and controllable in quality and effective.Type: GrantFiled: April 8, 2019Date of Patent: June 22, 2021Assignee: TIANJIN HONGRI JIAN DA KANG MEDICAL TECHNOLOGY CO., LTDInventors: Yi Juang Wu, Xiaoqing Yao, Changhai Sun, Li Tian, Xinying Zhao, Zhidong Han, Chuangyu Lin
-
Patent number: 11020343Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HC dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.Type: GrantFiled: August 23, 2019Date of Patent: June 1, 2021Assignee: Harm Reduction Therapeutics, Inc.Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
-
Patent number: 11013832Abstract: The present invention provides formulations comprising polymers and therapeutics and methods for their manufacture. The present invention also provides medical devices coated with such formulations and methods for their manufacture. The drug-loaded polymer formulations, solutions, and films tailor the drug release characteristics for medical devices.Type: GrantFiled: June 7, 2018Date of Patent: May 25, 2021Assignees: South Dakota Board of Regents, Sanford HealthInventors: Gopinath Mani, Sujan Lamichhane, Jordan Anderson, Tyler Remund, Patrick W. Kelly
-
Patent number: 11016120Abstract: A sharpening method for a probe tip of an Atomic Force Microscope (AFM) includes the steps of dripping a prepared slurry on a glass slide to form a droplet on the glass slide, where particles of the prepared slurry are diamond powder; infiltrating the tip to be sharpened with the prepared slurry; setting operation mode of the AFM to tapping in the fluid and lowering the probe into droplet till the probe cantilever beam is immersed completely in the droplet; setting vibration parameters, scanning parameters, and sharpening time, performing tip sharpening; and evaluating the sharpening results, and finishing sharpening. When the AFM works in a tapping mode in fluid, the tip of the self-excited oscillating probe is sharpened under the grinding effect of the diamond particles. The method is simple and effective, and easy to implement.Type: GrantFiled: September 30, 2020Date of Patent: May 25, 2021Inventors: Jianchao Chen, Jingxin Wu, Xiaoguang An, Guangming Song
-
Patent number: 11013824Abstract: An adhesive for hard tissue bonding which has a sufficient pot life and excellent biocompatibility and is replaced with bone over time, and an adhesive kit for hard tissue bonding are provided. In addition, bone cement is provided which has excellent biocompatibility and is replaced with bone over time. An adhesive for hard tissue bonding includes: a cyanoacrylate monomer; and beta-tricalcium phosphate or hydroxyapatite. An adhesive kit for hard tissue bonding includes: a liquid agent containing a cyanoacrylate monomer; and a powdery agent containing beta-tricalcium phosphate or hydroxyapatite. Bone cement includes: a cyanoacrylate polymer; and beta-tricalcium phosphate or hydroxyapatite.Type: GrantFiled: March 27, 2018Date of Patent: May 25, 2021Assignees: Chiba Institute of Technology, Fukuyamaika CorporationInventors: Kazuaki Hashimoto, Hirobumi Shibata, Syuhei Aida, Shigeo Fukuyama, Takashi Meguro, Shinya Tanaka
-
Patent number: 11000631Abstract: Devices, systems, and methods for applying a bioactive coating to an exterior surface of an implant are disclosed. In some embodiments, the bioactive coating may be applied to the surfaces of the implant within the operating room at the time of implantation. In one embodiment, the implant may be a temporary spacer used to temporary replace an implant in a patient suffering from an infection. The temporary spacer being, for example, an antibacterial material for fighting the infection. In some embodiments, the method includes providing a mold of the implant, and providing the bioactive coating within the mold. The method may further include inserting the implant into the mold so that the exterior surface of the implant contacts the bioactive coating, and then removing the implant from the mold.Type: GrantFiled: March 4, 2019Date of Patent: May 11, 2021Assignee: Smith & Nephew, Inc.Inventors: John Rose, Sied William Janna, Alisha Wilson Bergin
-
Patent number: 11000635Abstract: Disclosed are compositions comprised of Oxidized Cellulose (OC), such as oxidized regenerated cellulose (ORC), and an antibiotic comprised of minocycline, methods of preparation thereof and uses thereof.Type: GrantFiled: November 20, 2018Date of Patent: May 11, 2021Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.Inventors: Eve Montia, Dwayne Looney, Theresa Scheuble, Ronen Eavri, Roi Mashiach
-
Patent number: 11000553Abstract: Described herein are compositions and methods of treating a cardiac condition using modified placental tissue or an extract of a placental tissue, capable of recruiting stem cells or promoting healing in vivo and in vitro.Type: GrantFiled: September 10, 2018Date of Patent: May 11, 2021Assignee: MiMedx Group, Inc.Inventors: Thomas J. Koob, Hubbard Frank Burrows, III
-
Patent number: 10993797Abstract: An intraocular lenses having a plurality of drug-containing microspheres attached to the intraocular lens. The intraocular lenses can be used for patients undergoing cataract surgery and reduces the need for recurrent surgery, follow-up treatment or postoperative eye-drops. Also provides a method for manufacturing such an intraocular lens and the use of an intraocular lens in the treatment of cataract.Type: GrantFiled: February 23, 2017Date of Patent: May 4, 2021Assignee: VISUSNANO LIMITEDInventors: Elodie Jane Siney, Joanna Mary Gould, Darren Pitt, Philip Alexander
-
Patent number: 10993810Abstract: A containment body for making a spacer device or a device to be implanted in a human body that is suitable for treating a bone seat or a joint of the human body includes a base portion and side walls that extend from the base portion and that delimit between them at least one cavity, wherein the containment body has a plurality of pores and/or at least one opening, configured to place the at least one internal cavity in communication with the outside of the containment body.Type: GrantFiled: April 30, 2015Date of Patent: May 4, 2021Assignee: Cossington LimitedInventor: Augusto Magagnoli
-
Patent number: 10993968Abstract: Methods are disclosed for the collection and processing of amniotic material in animals. These methods involve collection of amniotic material directly during parturition or cesariean section in animals for the processing of regenerative wound treatments and tissue repairs without culturing or utilization of any excess manipulation of tissue. These materials are used to effect a cosmetic result.Type: GrantFiled: March 29, 2017Date of Patent: May 4, 2021Assignee: ANICELL BIOTECH, LLCInventors: Brandon Ames, Moises Barcelo-Fimbres
-
Patent number: 10987450Abstract: Provided is a lyophilized implant configured to fit at or near a bone defect to promote bone growth, the lyophilized implant containing a biodegradable polymer in an amount of about 0.1 wt. % to about 20 wt. % of the implant, mineral particles in an amount from about 0.1 wt. % to about 75 wt. % of the implant, and an oxysterol in an amount of about 5 wt. % to about 90 wt. % of the implant. Methods of making and using the implant are further provided.Type: GrantFiled: May 6, 2020Date of Patent: April 27, 2021Assignee: Warsaw Orthopedic, Inc.Inventors: Benjamin T. Reves, David S. Scher, Daniel A. Shimko
-
Patent number: 10987452Abstract: A method and device for local delivery of water-soluble or water-insoluble therapeutic agents to the surface of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with an amphiphilic polymer coating comprising a therapeutic agent and an amphiphilic polymer or co-polymer. The medical disposable device is inserted into a body lumen, and expanded to contact the amphiphilic polymer coating against the body lumen. The total solubility of the polymer or co-polymer in vivo prevents any embolic hazard associated with the amphiphilic polymer coating.Type: GrantFiled: May 25, 2019Date of Patent: April 27, 2021Assignee: THE SPECTRANETICS CORPORATIONInventors: Eugene T. Michal, Daniel J. Lerner, Matthew J. Pollman
-
Patent number: 10980923Abstract: There are disclosed implantable medical devices and apparatus for treating implantable medical devices during production, so as to cause the implantable medical devices to have abluminal surfaces and luminal surfaces with different functional characteristics and in particular surface energies. The luminal surfaces of the medical device are preferably coated with carbon, so as to have a low surface energy, which reduces the risk of thrombi forming when implanted into a patient's vessels. The abluminal surfaces are treated so as to have a high surface energy, such that a therapeutic, preferably bioactive, material, such as a drug, can adhere to the abluminal surfaces and preferably without any need for a containment layer such as polymer or other matrix material. Once the therapeutic material has been delivered into the tissue wall, the stent can remain within the patient's vessel without leaving any delivery artefacts, as occurs with some prior art drug eluting medical devices.Type: GrantFiled: February 16, 2018Date of Patent: April 20, 2021Assignee: Cook Medical Technologies LLCInventors: John Neilan, David Murray, James Butler
-
Patent number: 10975186Abstract: The invention relates to a process for preparing a graft copolymer comprising polyethylene, comprising the steps of: A) providing an ethylene copolymer comprising side chains having C?C bond and B) reacting the ethylene copolymer of step A) with an azide at an elevated temperature in the absence of a catalyst to obtain the graft copolymer, wherein the azide compound is an azide compound having a functional group or a polymer having an azide group.Type: GrantFiled: January 2, 2017Date of Patent: April 13, 2021Assignee: SABIC GLOBAL TECHNOLOGIES B.V.Inventors: Diego Mauricio Castaneda Zuniga, Peter Neuteboom, Jan Nicolaas Eddy Duchateau, Markus Busch, Sebastian Bruno Fries
-
Patent number: 10975490Abstract: An apparatus for etching one side of a semiconductor layer, including at least one etching tank for receiving an electrolyte, a first electrode, which is arranged to make electrical contact with the electrolyte located in the etching tank during use, at least a second electrode, which is arranged to make indirect or direct electrical contact with the semiconductor layer, at least one electric current source, which is electrically conductively connected to the first and the second electrode to produce an etching current, and at least one transport apparatus for transporting the semiconductor layer relative to the etching tank in such a way that substantially only an etching side of the semiconductor layer that is to be etched can be wetted by the electrolyte located in the etching tank during use.Type: GrantFiled: December 8, 2016Date of Patent: April 13, 2021Assignee: NexWafe GmbHInventors: Stefan Reber, Kai Schillinger
-
Patent number: 10967100Abstract: The present invention relates to methods for making wear and oxidation resistant polymeric materials by high temperature melting. The invention also provides methods of making medical implants containing cross-linked antioxidant-containing tough and ductile polymers and materials used therewith also are provided.Type: GrantFiled: December 21, 2018Date of Patent: April 6, 2021Assignee: THE GENERAL HOSPITAL CORPORATIONInventors: Ebru Oral, Orhun K. Muratoglu
-
Patent number: 10967570Abstract: A device and method for printing lumen tissue constructs and a 3D bioprinter are disclosed. The device has a spray sprayhead assembly and a bioprinting platform. The spray sprayhead assembly prints a biological construct on an inner surface of a lumen tissue by the bioprinting platform. Problems, such as, recurrence of thrombus and restenosis of a lumen after the lumen tissue has been transplanted for a long time, can be avoided. The biological reliability of the lumen tissue can be improved.Type: GrantFiled: April 27, 2018Date of Patent: April 6, 2021Assignee: REVOTEK CO., LTDInventors: Yijun Li, Junxuan He, Zhi Jiang, Xiaolin Hu, Leqing Zhang, Deming Wang
-
Patent number: 10960380Abstract: An adsorbent, which can be produced by a method in which a particle size, a pore size, a specific surface area or the like can be easily controlled, and is suitable for isolation of biomolecules. The adsorbent contains aggregates of calcium phosphate-based particles, and has an average pore size of 15 to 36 nanometers and a specific surface area of 40 to 90 m2/mL when measurement is carried out by mercury porosimetry.Type: GrantFiled: December 20, 2016Date of Patent: March 30, 2021Assignees: JNC CORPORATION, SofSera CorporationInventors: Yoshihiro Matsumoto, Akihiro Uchida, Yasuto Umeda
-
Patent number: 10959876Abstract: A dental appliance is provided. The dental appliance includes a dental form configured to receive a portion of a dental arch of an individual, and an adhesive strip comprising a first side and a second side. The first side of the adhesive strip is attached to a portion of the dental form. The second side of the adhesive strip comprises a mucoadhesive configured to adhere the adhesive strip to a tongue of the individual such that the tongue of the individual can be selectively attached to the dental appliance.Type: GrantFiled: September 15, 2017Date of Patent: March 30, 2021Inventor: Martin N. Gorman
-
Patent number: 10939990Abstract: A laser is used to form openings within a graft material to selectively enhance permeability of a prosthesis for tissue integration therein. A feature of utilizing a laser to create the openings for tissue integration builds from its tunability. More particularly, the laser precisely places openings in any pattern and location, and on any textile that forms the graft material. Further, the power and focus of the laser is precisely adjusted to control the diameter and shape of the openings. All parameters of the openings can be controlled at will, allowing for the opportunity to selectively enhance and optimize the permeability of the graft material in a vessel.Type: GrantFiled: April 11, 2018Date of Patent: March 9, 2021Assignee: MEDTRONIC VASCULAR, INC.Inventors: Zachary Borglin, Matt Petruska, Keith Perkins, Julie Benton
-
Patent number: 10933172Abstract: Implantable medical devices are provided. In one embodiment, a device includes a body having an external surface defining an outer profile of the device. The body includes a porous matrix including a series of interconnected macropores defined by a plurality of interconnected struts each including a hollow interior. A filler material substantially fills at least a portion of the series of interconnected macropores. The external surface of the body includes a plurality of openings communicating with the hollow interior of at least a portion of the plurality of interconnected struts. In a further aspect of this embodiment, the external surface includes exposed areas of the filler material and porous matrix in addition to the exposed openings. In another aspect, the porous matrix is formed from a bioresorbable ceramic and the filler material is a biologically stable polymeric material. Still, other aspects related to this and other embodiments are also disclosed.Type: GrantFiled: April 1, 2016Date of Patent: March 2, 2021Assignee: Warsaw Orthopedic, Inc.Inventors: Anthony J. Melkent, Brian R. Thoren, Timothy J. N. Smith, Ian D. Grant, Ian R. Dunkley
-
Patent number: 10932910Abstract: The present invention provides a process to functionalize nanofiber membrane (NFM) on a total joint replacement (TJR) implant surface to support bone ingrowth and reduce macrophage-associated inflammation, the process comprising amending the implant surface by laser cutting microgrooves greater than 100 ?m in depth to protect functional PCL NFM from applied loading, induce a higher amount of osteoblast cell function, increase implant-bone contact area, and serve as a reservoir for the local delivery of biomolecules to increase osseointegration of the implant; depositing aligned fibers on the implant surface, the fibers aligned in the direction of the microgrooves and collected in layers until a thickness less than 30 ?m is reached and preferably in the range of 1 ?m to 10 ?m. Biofunctionalized NFM are used to indirectly attach biomolecules on said implant surface, or extracellular matrix proteins with biomolecules are immobilized and deposited on the PCL NFM coated implant.Type: GrantFiled: January 15, 2019Date of Patent: March 2, 2021Assignee: University of Central OklahomaInventors: Morshed Khandaker, Shahram Riahinezhad, William Paul Snow